Will FDA advisers recommend a multi-cancer blood test for approval? They'll vote — Live Feedhttps://www.live-feeds.com/feed/will-fda-advisers-recommend-a-multi-cancer-blood-test-for-approval-they-ll-voteContinuously updated, source-cited coverage. FDA Advisers Back Grail Multi-Cancer Blood Testhttps://www.live-feeds.com/feed/will-fda-advisers-recommend-a-multi-cancer-blood-test-for-approval-they-ll-votehttps://www.live-feeds.com/feed/will-fda-advisers-recommend-a-multi-cancer-blood-test-for-approval-they-ll-vote#u83693Fri, 25 Sep 2026 10:40:08 +0000U.S. food and drug administration advisers voted to back grail's multi-cancer early detection blood test, concluding that its benefits outweigh its risks. The panel voted on the premarket approval application for the galleri test, which aims to spot early signs of more than fifty types of cancer before symptoms appear. While federal health advisers expressed doubts about how definitive the results may be and whether the test works, they determined there was a reasonable assurance of safety for its proposed use.Why it mattersMulti-cancer early detection blood tests represent a major fronti